Expression and Signal Transduction of the FLT3 Tyrosine Kinase Receptor

Acta Haematologica

Volumn 95, Issue 3-4, 1996, Pages 218-223

  Rosnet, Olivier ^a   Bühring, Hans Jörg ^d   De Lapeyriére, Odile ^a   Beslu, Nathalie ^b   Lavagna, Chrystel ^a   Marchetto, Sylvie ^a   Rappol, Irene ^d   Drexler, Hans G ^e   Birg, Françoise ^c   Rottapel, Robert ^g   Hannum, Charles ^f   Dubreuil, Patrice ^b   Birnbaum, Daniel ^a  

^a Molecular Oncology   (France)

^b Molecular Hematology   (France)

^c INSERM   (France)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^f MERCK RESEARCH LABORATORIES   (United States)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

CD34; Chromosome 13; FLT3 receptor; Hematopoiesis; Hematopoietic stem cells; KIT receptor; Signal transduction; Tyrosine kinase

Indexed keywords

CELL RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE;

ACUTE LEUKEMIA; ANIMAL CELL; BLAST CELL; BONE MARROW CELL; CHROMOSOME 5; CONFERENCE PAPER; FETUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

ACUTE DISEASE; ANIMALS; BONE MARROW; BONE MARROW CELLS; EVOLUTION, MOLECULAR; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MEMBRANE PROTEINS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 9044233643     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203881     Document Type: Article

References (29)

1. Krauss J: Hematopoietic stem cell gene replacement therapy. Biochim Biophys Acta 1992;1114:193-207.
2. Whetton A, Dexter M; Influence of growth factors and substrates on differentiation of hematopoietic stem cells. Curr Opin Cell Biol 1993; 5:1044-1049.
3. Rosnet O, Marchetto S, deLapeyriere O, Bim-baum D: MurineFlt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 1991;6:1641-1650.
4. Matthews W, Jordan C, Wiegand G, Pardoll D, Lemischla I: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enrichcd populations. Cell 1991;65:1143— 1152.
5. Small D, Levenstein M, Kin E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak M, Gewirtz A, Civin C: STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitors/stem cells. Proc Natl Acad Sci USA 1994; 91:459-463.
6. Imbert A, Rosnet O, Marchetto S, Ollendorff V, Bimbaum D, Pebusque MJ: Characterization of a yeast artificial chromosome from human chromosomc band 13q 12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes. Cytogenetic Cell Genet 1994;67:175— 177.
7. Agnes F, Shamoon B, Dina C, Rosnet O, Bimbaum D, Galibert F: Genomic structure of the downstream part of the human FLT3 gene: Exon/intron structure conservation among genes encoding receptor tyrosine kinase (RTK) of subclass III. Gene 1994;145:283-288.
8. Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonr.clle C, Toiron Y, Birg F, Bimbaum D: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82:1110-1119.
9. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Bimbaum D, Dubreuil P: Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 1993;8: 909-918.
10. Rousset D, Agnes F, Lachaume P, Andre C, Galiberi F: Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains. J Mol Evol, in press.
11. Lyman S, James L, Vanden Bos T, deVries P, Brasel K, Gliniak B, Hollingsworth L, Picha K, McKenna H, Splett R, Fletcher F, Maraskov-sky E, Farrah T, Foxworthe D, Williams D, Beckmann P: Molecular cloning of a ligand for the Flt3/Flk2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 1993:75:1157-1167.
12. Hannum C, Culpepper J, Campbell D, McCla-nahan T, Zurawski S, Bazan F, Kastelcin R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Mcnon S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Du-breuil P, Bimbaum D, Lee F: Ligand for FLT3/ FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature 1994:368:643-648.
13. Lyman S, Williams D: Biology and potential clinical applications of Flt3 ligand. Curr Opin Hematol 1995;1:177-181.
14. Lyman S, James L, Johnson L, Brasel K, deVries P, Escobar S, Downey H, Splett R, Beckmann P, McKenna H: Cloning of the human homologuc of the murine Flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 1994;83:2795-2801.
15. Muench M, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum C, Culpepper J, Lee F, Namikaw-a R: FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995;85:963-972.
16. Hirayama F, Lyman S, Clark S, Ogawa M: Thefll3ligand supports proliferation of lymphohe-matopoietic progenitors and early B-lymphoid progenitors. Blood 1995;85:1762-1768.
17. Rossner M, McArthur G, Allen J, Metcalf D: Fms-likc tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDCP1 cells that is qualitatively similar to the signal delivered byc-Fms. Cell Growth Differ 1994;5: 549-555.
18. Zeigler F, Bennet B, Jordan C, Spencer S, Baumheuter S, Carroll K, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 1994;84:2422-2430.
19. Birg F, Courcoul M, Rosnet O, Bardin F, Pe-busque MJ, Marchetto S, Tabilio A, Mannoni P, Bimbaum D: Expression of the FMS/KIT-like gene FLT3 in human acutc leukemias of the myeloid and lymphoid lineages. Blood 1992;80:2584-2593.
20. DaSilva N, Hu ZB, Ma W, Rosnet O, Bimbaum D, Drexler H: Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 1994;8:885-888.
21. Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Bimbaum D, Dirks W, Drexler H: Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9:1368-1372.
22. deLapeyriere O, Naquet P, Planche J, Marchetto S, Rottapel R, Gambarelli D, Rosnet O, Bimbaum D: Expression ofFlt3tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues. Differentiation 1995;58:351 — 359.
23. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Amoulet C, Chaban-non C, Kanz L, Hannum C, Birnbaum D: The human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia, in press.
24. Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H, Drexler HG: Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia, in press.
25. Dosil M, Wang S, Lemischka I: Mitogenic signaling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 1993;13:6572-6585.
26. Rottapel R, Turck C, Casteran N, Liu X, Birnbaum D, Pawson T, Dubreuil P: Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene 1994;9:1755-1765.
27. Casteran N, Rottapel R, Beslu N, Lecocq E, Birnbaum D, Dubreuil P: Analysis of the mito-genic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase. Cell Mol Biol 1994;40:443-456.
28. Kaushansky K, Karplus A: Hematopoietic growjh factors: Understanding functional diversity in structural terms. Blood 1993;82: 3229-3240.
29. Mackarehtschian K, Hardin J, Moore K, Boast S, GoffS, Lcmischka I: Targeted disruption of theFlk2/Flt3gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995;3:147-161.